MedPath
HSA Approval

VASCOTEN 50 TABLET 50 mg

SIN07161P

VASCOTEN 50 TABLET 50 mg

VASCOTEN 50 TABLET 50 mg

October 8, 1992

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C07AB03

atenolol

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD

Active Ingredients

ATENOLOL

50 mg

Atenolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VASCOTEN 50 TABLET 50 mg - HSA Approval | MedPath